Recommendation
- https://www.mayoclinic.org/diseases-conditions/nonalcoholic-fatty-liver-disease/symptoms-causes/syc-20354567Mayo ClinicNonalcoholic fatty liver disease - Symptoms and causes - Mayo ClinicApr 4, 2024 ... NAFLD ranges in severity from hepatic steatosis, called fatty liver, to a more severe form of disease called nonalcoholic steatohepatitis (NASH) ...
- https://www.niddk.nih.gov/health-information/liver-disease/nafld-nashNational Institute of Diabetes and Digestive and Kidney DiseasesNonalcoholic Fatty Liver Disease (NAFLD) & NASH - NIDDKDefinition & Facts. Nonalcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in your liver. Nonalcoholic fatty liver (NAFL) and ...
- https://www.nature.com/articles/nrgastro.2017.109Global burden of NAFLD and NASH: trends, predictions, risk factors ...Sep 20, 2017 ... NAFLD is one of the most important causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming ...
- https://www.niddk.nih.gov/health-information/liver-disease/nafld-nash/definition-factsNational Institute of Diabetes and Digestive and Kidney DiseasesDefinition & Facts of NAFLD & NASH - NIDDKNAFLD (also referred to as metabolic dysfunction-associated steatotic liver disease, or MASLD), is a condition in which excess fat builds up in your liver.
- https://pubmed.ncbi.nlm.nih.gov/31279902/PubMedThe global epidemiology of NAFLD and NASH in patients with type ...This study provides the global prevalence rates for NAFLD, NASH, and advanced fibrosis in patients with T2DM.
- https://www.sciencedirect.com/science/article/pii/S0168827817322821Genetics and epigenetics of NAFLD and NASH: Clinical impact ...The premise for this review is to discuss the status of research into important genetic and epigenetic modifiers of NAFLD progression.
- https://pubmed.ncbi.nlm.nih.gov/29844588/PubMedNoninvasive biomarkers in NAFLD and NASH - current progress ...Nonalcoholic fatty liver disease (NAFLD) affects 25% of the global adult population and is the most common chronic liver disease worldwide.
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953348/PubMed Central (PMC)Emerging Role of Nuclear Receptors for the Treatment of NAFLD ...... NAFLD and NASH. The TZDs rosiglitazone and pioglitazone were tested in ... Abbreviations. NAFLD, Non-Alcoholic Fatty Liver Disease; NASH, Non-Alcoholic ...
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6365925/PubMed Central (PMC)The role of the microbiome in NAFLD and NASH - PMCIn this review, we will explore the impact of gut microbiota and microbiota‐derived compounds on the development and progression of NAFLD and NASH.
- https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE126848GSE126848Non-alcoholic fatty liver disease (NAFLD) ... The hepatic molecular events underlying the development of NAFLD and transition to NASH are poorly understood.
Recommend
All Categories
Others
Privacy Policy
Terms of Use
Welcome to kkinews.com, we strive to provide you with the latest news,
hot topics and in-depth articles.
Whether it's real-time news or in-depth analysis from multiple angles,
you can easily get it here. kkinews.com aims to provide users with a
convenient and comprehensive information acquisition experience to
help you always stay at the forefront of information.
Copyright © 2024 Kkinews. All rights reserved